Tevogen Bio and Microsoft expand AI collaboration to PredicTcell tech

Full Article
Tevogen Bio and Microsoft expand AI collaboration to PredicTcell tech

Tevogen Bio has strengthened its partnership with Microsoft to enhance its AI-driven PredicTcell technology. This collaboration aims to utilize Microsoft's cloud capabilities and AI expertise to expedite the detection of targets and improve pre-clinical processes. The integration of Microsoft's advanced AI tools into Tevogen.AI is expected to significantly boost the company's immunotherapy pipeline.

The partnership focuses on expanding the ExacTcell Technology pre-clinical pipeline, leveraging machine learning for faster target discovery through genomic data analysis. Additionally, algorithms will be developed to decode interactions between T-cells and human leukocyte antigens, paving the way for new therapeutic opportunities. Tevogen Bio is also exploring HPV treatments, further showcasing the potential of AI in personalized medicine.

• Tevogen Bio integrates Microsoft's AI tools to enhance immunotherapy development.

• Collaboration aims to accelerate target discovery using machine learning techniques.

Key AI Terms Mentioned in this Article

Machine Learning

Machine learning is utilized to analyze genomic datasets for faster target discovery.

Predictive Precision T-cell Targeting

This technology aims to enhance the targeting of T-cells in immunotherapy applications.

Algorithms

Algorithms will be developed to decode interactions between T-cells and human leukocyte antigens.

Companies Mentioned in this Article

Tevogen Bio

Tevogen Bio focuses on advancing immunotherapy through AI-driven technologies like PredicTcell.

Microsoft

Microsoft provides cloud and AI capabilities to enhance Tevogen Bio's immunotherapy efforts.

Get Email Alerts for AI News

By creating an email alert, you agree to AIleap's Terms of Service and Privacy Policy. You can pause or unsubscribe from email alerts at any time.

Latest Articles

Alphabet's AI drug discovery platform Isomorphic Labs raises $600M from Thrive
TechCrunch 6month

Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600

AI In Education - Up-level Your Teaching With AI By Cloning Yourself
Forbes 6month

How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.

Trump's Third Term - How AI Can Help To Overthrow The US Government
Forbes 6month

Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.

Sam Altman Says OpenAI Will Release an 'Open Weight' AI Model This Summer
Wired 6month

Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.

Popular Topics